Consultations of Gastroenterology practitioners are frequently sought for many complex issues relating to acute and chronic liver disease. Many of the disease entities are uncommon and complicated in scope. Liver disease may occur in the setting of other chronic medical conditions and involve other organ systems, with recommendations for diagnostic strategies and therapeutic approaches somewhat challenging. Serious consequences are often the rule with misdiagnosed or inadequately treated liver disease. Dr. Flamm has provided a framework for approaching consultation for common liver-related problems for the gastroenterology practitioner. Articles are devoted to the following topics: Common Findings and Interpretation for the Clinician; Genetic Testing in Liver Disease: What to Order and When; Acute Liver Failure; Liver Disease in Oncology Patients; Primary Sclerosing Cholangitis: What the Gastroenterologist/Hepatologist Needs to Know; An Update on the Treatment and Follow up of Patients with PBC; Wilson’s Disease: Diagnosis, Treatment, and Follow Up; Follow Up of the Post-Liver Transplantation Patient: A Primer for the Practicing Gastroenterologist; Liver Disease in Patients on Total Parenteral Nutrition; Treatment Strategies in NAFLD: What’s Coming; Resistance Testing in Chronic HCV; and HCV genotype 3: Treatment Approach and Natural History.
Our issues help you manage yours.
Table 2 Recommended treatment of hepatitis C virus–uninfected recipients of livers from hepatitis C virus–viremic donors Treatment-naıve and -experienced patients with genotype 1–6 infection in the allograft without cirrhosis ...
Nonalcoholic Steatohepatitis in Children Stavra A. Xanthakos, MD, MS KEYWORDS Nonalcoholic fatty liver disease Cirrhosis Vitamin E Liraglutide Bariatric surgery KEY POINTS Nonalcoholic fatty liver disease (NAFLD) is currently the ...
NATURAL COURSE Signs and Symptoms Fatigue and pruritus are the most commonly reported symptoms by patients with PBC ... which is a common manifestation of all cholestatic liver diseases, is reported in 40% to 80% of patients with PBC.
In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Pierre Gholam has put together topics that provide a current clinical update on the treatment and management of patients with drug-induced liver injury (DILI).
In collaboration with Consulting Editor, Dr. Norman Gitlin, Guest Editors Drs. Andres Cardenas and Thomas Reiberger have created an up-to-date monograph on the complications of cirrhosis.
“precision medicine” approach, in which the specific treatment is tailored to a patient's individual metabolomics, ... CLINICS CARE POINTS Alcoholic hepatitis (AH) is a clinical diagnosis, however there are laboratory markers that can ...
Internationally renowned experts present topics related to obesity, nutrition, and liver disease in this issue.
INTRODUCTION Liver cancer is the sixth most commonly diagnosed cancer and accounts for the fourth leading cause of ... the years 2000 and 2012, and is projected to continue to rise.3 Because of its aggressive nature and that, typically, ...
CLINICS IN LIVER DISEASE THE CLINICS ARE AVAILABLE ONLINE! Access your subscription at: www.theclinics.com This page intentionally left blank Preface Mitchell L. Shiffman, MD,. FORTHCOMING ISSUES RECENT ISSUES February 2022 The Evolving ...